call-us :+919958984431

ROLIMUS 10 (Everolimus Tablets 10mg)

ROLIMUS 10 (Everolimus Tablets 10mg)

Product Details:

  • Drug Type Drug Solutions
  • Ingredients everolimus tablet
  • Physical Form Tablets
  • Function Anti-Cancer
  • Recommended For aniti cancer
  • Dosage 10mg
  • Dosage Guidelines as directed by physician
  • Supply Ability : 7 Milligram Per Day
7000 INR/Box

Price And Quantity

  • 7000.00 - 9000.00 INR/Box
  • 7000 INR/Box
  • 10 Milligram

Product Specifications

  • Adults, Women
  • 1*10 Unit
  • as directed by physician
  • everolimus tablet
  • Drug Solutions
  • Tablets
  • 10mg
  • aniti cancer
  • Anti-Cancer
  • stor below 25degree c

Trade Information

  • delhi
  • Letter of Credit at Sight (Sight L/C), Letter of Credit (L/C), Delivery Point (DP), Days after Acceptance (DA), Cheque, Cash in Advance (CID), Cash Advance (CA), Cash Against Delivery (CAD)
  • 7 Milligram Per Day
  • 7 Days
  • Contact us for information regarding our sample policy
  • Africa, Middle East, Western Europe, Eastern Europe, South America, North America, Central America, Australia, Asia
  • All India
  • cipla

Product Description

Rolimus 10 Tablet is prescribed to transplant patients so as to minimize the case of organ rejection. This medication regulates the response of immune system of the body so that the body accepts the new organ. This medication can be prescribed along with other medication for the treatment of cancers of breast, pancreas, lungs and kidney. The patients must follow the prescription and take the medication in accurate dosage and for prescribed duration. The ROLIMUS 10 (Everolimus Tablets 10mg) can be taken with or without food. This medication can cause certain side effects in patients, like weakness, fatigue, fever, infection, cough, etc. In most people, these side effects disappear as the body starts to adjust to the medicine.


* Tips on getting accurate quotes. Please include product name, order quantity, usage, special requests if any in your inquiry.

"Our export market include China, Russia, Ukraine, Vietnam, Afghanistan, Philippines, Nepal and Italy."